MAPT and Alzheimer disease: A significant increase in the t-Tau/Aβ42 ratio and a decrease in the Aβ42/p-Tau ratio in AD-dementia patients compared to controls was also observed, while MCI patients had intermediate and significantly different values from the other groups.